Preventing Cholestasis Using SMOFLipid®

NCT01585935 · clinicaltrials.gov ↗

PHASE4

Phase

COMPLETED

Status

230

Enrollment

OTHER

Sponsor class

Conditions

Cholestasis
Psychomotor Disorders, Developmental

Interventions

DRUG: SMOFLIPID
DRUG: INTRALIPID

Sponsor

Medical University of Vienna